Filter
-
(206)
-
(176)
-
(8)
-
(190)
-
(66)
-
(10)
-
(252)
-
(89)
-
(1)
-
(49)
-
(287)
-
(16)
-
(36)
-
(799)
-
(43)
-
(14)
-
(1210)
-
(404)
-
(463)
-
(439)
2831 - 2840
of 7055 results
-
AbstractT-817MA is an orally available agent, which is in the phase 2 clinical trial for Alzheimer’s disease (AD) in the US and Japan. We previously reported that T-817MA recovered cognitive impairment in an AD animal model (Kimura et al., SfN 2006). T-817MA de...Nov 16, 2016
